Skip to main contentAccess keys help

[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Languages
Last Updated: Friday, 18 March, 2005, 17:27 GMT
HIV Kenya protest at patent law
By Muliro Telewa
BBC News, Nairobi

HIV campaigners in Nairobi
The protesters say they may soon not be able to afford medicine
Police in Kenya have stopped hundreds of people living with HIV and Aids from demonstrating at the Indian High Commission in Nairobi.

The protests, also planned in Uganda and Tanzania, are over an Indian draft law which may block poor countries' access to anti-retroviral (ARV) drugs.

According to WTO rules, India is obliged to protect and enforce drug patents from the start of this year.

This will stop routine generic drug production, protesters say.

The production has led to major reductions in the cost of ARV medicines, as well as other medicines that treat other diseases affecting millions of people in developing countries.

Message for India

Some protesters gathered in Nairobi's Uhuru Park, singing to console themselves after the police banned their planned demonstration through the town to the Indian High Commission.

These are $20 a month as compared to $395 for [patented] products
James Kamau

The Aids victims, accompanied by some members of various pressure groups, said it was necessary to let Kenyans know that they may soon not be able to afford medicine in Kenya because of India and the World Trade Organisation (WTO).

James Kamau, a self-declared HIV-positive patient, showed me some of his Indian-manufactured ARV drugs.

"These are $20 a month as compared to $395 for [patented] products," he said.

The police agreed to escort representatives of the protesters to the high commission to hand over their letter of protest.

'Let us protest'

They want India to ignore what they termed "WTO dictatorship", by which India is obliged to observe patents according to its rules on trade-related aspects of intellectual property rights.

Although they eventually presented their letter to the high commission, the group complained that they should have been allowed to demonstrate.

They said it was sad that although the government admitted that between 500 and 700 people died in the country daily from Aids-related diseases, it was not ready to give them a chance to express their opinion.

The Indian parliament will discuss amendments to the country's Patent Act of 1970 in the next few weeks.

If the amendment is passed manufacturers of generic drugs in India, where Kenya gets most of its ARVs, will pay some commissions to originators of the drugs for a period of 20 years.


SEE ALSO:
Texts aim to fight Aids in Kenya
01 Dec 04 |  Technology
India facing new drugs patent law
18 Mar 05 |  South Asia


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
AmericasAfricaEuropeMiddle EastSouth AsiaAsia Pacific